SynthesisMultiple sclerosis and related disorders2022
Autoimmune encephalitis associated with COVID-19: A systematic review.
Synthesis in Multiple sclerosis and related disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.
- Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025Pooled it
- Associations of viral infections and antiviral vaccinations with anti-NMDAR and other forms of autoimmune encephalitis.Brain, behavior, & immunity - health · 2026Review
- Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 Pandemic.Neurology(R) neuroimmunology & neuroinflammation · 2026Article
- A Rare Case of Anti-CASPR2 Encephalitis as the Presenting Manifestation of Hepatitis B Virus Infection.Annals of Indian Academy of Neurology · 2026Article
- Article
- Clinical Features of Central Nervous System Complications Caused by the SARS-CoV-2 Omicron Variant.Immunity, inflammation and disease · 2025Article
- Impact of the COVID-19 Outbreak on the Incidence of Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes Associated Antibodies in Singapore.Brain and behavior · 2025Article
- NMDA receptor antagonists mitigate COVID-19-induced neuroinflammation and improve survival in a mouse model.Scientific reports · 2025Article
- Leucine-rich glioma-inactivated protein 1 antibody-positive limbic encephalitis in a patient with an early-stage asymptomatic breast cancer.BMJ case reports · 2025Article
- Autoimmune encephalitis associated with anti-SOX1 autoantibodies in COVID-19: A case report.IDCases · 2025Article
- New onset autoimmune disease following a SARS-CoV-2 infection: A systematic review protocol.PloS one · 2025Article
- Autoimmune Encephalitis Induced by SARS-CoV-2 Infection Treated with Thymectomy.Annals of thoracic surgery short reports · 2024Article
- Features of the clinical course of Autoimmune Encephalitis Associated with various antibodies.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024Observational
- Cytokine profile and case series of tract-specific myelitis following SARS-CoV-2 infection.Current journal of neurology · 2024Article
- Predicting factors for acute encephalopathy in febrile seizure children with SARS-CoV-2 omicron variant: a retrospective study.BMC pediatrics · 2024Article
- An Autopsy-proven Case-based Review of Autoimmune Encephalitis.Experimental neurobiology · 2024Review
- Case report: A case of anti-glycine receptor encephalomyelitis triggered by post-transplant or COVID-19 infection?Frontiers in neurology · 2024Article
- Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy/immunology clinic.Frontiers in psychiatry · 2024Review
- Controversies in COVID-19: Diagnostic Evaluation and Management in Neuro-COVID.Advances in experimental medicine and biology · 2024Review
- Behavioral and Sleep Disorders in Children and Adolescents following COVID-19 Disease: A Case-Control Study.Children (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThere are increasing reports of COVID-19 related neurological complications which may be due to direct viral invasion, or immune mediated inflammatory diseases such as autoimmune encephalitis and ADEM (acute demyelinating encephalomyelitis). In this study, a systematic review is presented of the reported cases infected by the COVID-19 who were diagnosed with various forms of autoimmune encephalitis (AE).
methodsThe authors searched three databases including PubMed, Scopus, and Web of science for extracting original articles on coronavirus/ COVID-19 and AE.
resultsEighteen articles were considered in this study, including 15 case reports, and three case series with a total of 81 patients. Among the studies, 19 cases were reported with AE including 7 (37%) cases of limbic encephalitis, 5 (26%) patients with anti-N-methyl-d-aspartate (NMDA) receptor encephalitis, 2 (11%) with AE presenting as new-onset refractory status epilepticus (NORSE), 1 (5%) case of steroid-responsive encephalitis, and 4 (21%) cases with an unknown type of AE.
conclusionOur systematic review revealed evidence on AE development in patients infected with the COVID-19. Clinicians should be aware of the possible diagnosis of AE when considering other neurological differential diagnosis in SARS-CoV-2 infected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.